BR112018067423A2 - composições que compreendem colina e uso das mesmas - Google Patents

composições que compreendem colina e uso das mesmas

Info

Publication number
BR112018067423A2
BR112018067423A2 BR112018067423A BR112018067423A BR112018067423A2 BR 112018067423 A2 BR112018067423 A2 BR 112018067423A2 BR 112018067423 A BR112018067423 A BR 112018067423A BR 112018067423 A BR112018067423 A BR 112018067423A BR 112018067423 A2 BR112018067423 A2 BR 112018067423A2
Authority
BR
Brazil
Prior art keywords
choline
potential
composition
compositions
female subject
Prior art date
Application number
BR112018067423A
Other languages
English (en)
Inventor
Silva Zolezzi Irma
HAUSER Jonas
Schneider Nora
DEONI Sean
Bartfai Tamas
Mary Samuel Tinu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112018067423A2 publication Critical patent/BR112018067423A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

a presente invenção refere-se a uma composição que compreende colina para uso na promoção, suporte ou otimização de um ou mais dos seguintes: (i) remielinização; (ii) estrutura cerebral; (iii) conectividade cerebral; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizagem; e (vii) funcionamento cognitivo; em uma prole de um indivíduo do sexo feminino, sendo que a dita composição é para administração ao indivíduo do sexo feminino.
BR112018067423A 2016-03-30 2017-03-30 composições que compreendem colina e uso das mesmas BR112018067423A2 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662328105P 2016-04-27 2016-04-27
PCT/EP2016/080790 WO2017167417A1 (en) 2016-03-30 2016-12-13 Compositions comprising choline and their use
PCT/EP2017/057571 WO2017167895A1 (en) 2016-03-30 2017-03-30 Compositions comprising choline and their use

Publications (1)

Publication Number Publication Date
BR112018067423A2 true BR112018067423A2 (pt) 2019-01-22

Family

ID=57758563

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112018011394A BR112018011394A2 (pt) 2016-03-30 2016-12-13 composições que compreendem colina e uso das mesmas
BR112018067423A BR112018067423A2 (pt) 2016-03-30 2017-03-30 composições que compreendem colina e uso das mesmas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112018011394A BR112018011394A2 (pt) 2016-03-30 2016-12-13 composições que compreendem colina e uso das mesmas

Country Status (8)

Country Link
EP (1) EP3435991A1 (pt)
CN (2) CN108697671A (pt)
BR (2) BR112018011394A2 (pt)
CA (2) CA3003656A1 (pt)
MX (3) MX2018008518A (pt)
PH (1) PH12018501782A1 (pt)
SG (2) SG11201803026RA (pt)
WO (2) WO2017167417A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201900604TA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
US20210353566A1 (en) * 2020-05-12 2021-11-18 Massachusetts Institute Of Technology The use of choline supplementation as therapy for apoe4-related disorders
CN112655969A (zh) * 2021-03-15 2021-04-16 江苏艾兰得营养品有限公司 酒石酸氢胆碱颗粒、含有其的片剂及制备方法
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84680T1 (de) 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
AU4555799A (en) * 1998-06-12 1999-12-30 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
CA2371696C (en) 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
CN1778199A (zh) * 2004-11-24 2006-05-31 王维义 孕产妇营养素
BRPI0607666A2 (pt) * 2005-04-28 2009-09-22 Enzymotec Ltd misturas de lipìdeo polar, sua preparação e uso
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
ITGE20110050A1 (it) * 2011-04-29 2012-10-30 Marco Zipoli Alimento, in particolare una bevanda per l'alimentazione umana
EP3389415A1 (en) * 2015-12-14 2018-10-24 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
BR112018010265B1 (pt) * 2015-12-14 2022-08-30 Société des Produits Nestlé S.A. Composições nutricionais sintéticas para promover mielinização de novo
AU2016374164A1 (en) * 2015-12-14 2018-04-19 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain

Also Published As

Publication number Publication date
CA3003656A1 (en) 2017-10-05
MX2018008518A (es) 2018-08-16
CN108697672A (zh) 2018-10-23
CA3017842A1 (en) 2017-10-05
WO2017167417A1 (en) 2017-10-05
WO2017167895A1 (en) 2017-10-05
EP3435991A1 (en) 2019-02-06
CN108697671A (zh) 2018-10-23
SG11201803026RA (en) 2018-05-30
SG11201806422XA (en) 2018-10-30
MX2022012236A (es) 2023-01-24
MX2018011680A (es) 2019-01-10
PH12018501782A1 (en) 2019-06-17
BR112018011394A2 (pt) 2018-12-04

Similar Documents

Publication Publication Date Title
BR112018067999A2 (pt) composições compreendendo ácidos graxos e seu uso
BR112018067423A2 (pt) composições que compreendem colina e uso das mesmas
BR112018010335A2 (pt) composição nutricional e fórmula para bebês para promover mielinização do cérebro
CL2018001089A1 (es) Sales de valbenazina y polimorfos de las mismas.
BR112015005743A2 (pt) derivados tricíclicos de quinoxalina e quinolina
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112017017840A2 (pt) composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
DOP2016000047A (es) Compuestos y composiciones como inhibidores de la mek
BR112018011380A2 (pt) composições que compreendem fosfolipídeo e uso das mesmas
BR112016006388A2 (pt) inibidor seletivo da fosfatidilinositol 3-quinase gama
BR112018006445A2 (pt) métodos para tratar distrofia muscular
CL2017000231A1 (es) Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos
BR112017019750A2 (pt) processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol
BR112018067730A2 (pt) composições que compreendem minerais e seu uso
BR112018068369A2 (pt) composições e uso das mesmas
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
BR112017004325A2 (pt) composição nutricional para uso na promoção da maturação e/ou do reparo do intestino e/ou do fígado
BR112016021471A8 (pt) derivados de ácido acético azaindol e seu uso como moduladores de receptor d2 de prosrtglandina
BR112014016346A2 (pt) uso de glutamina ou de uma composição
BR112015017768A2 (pt) compostos
WO2017167898A3 (en) Compositions comprising vitamins and their use
BR112016021443A8 (pt) Derivados de ácido acético azaindol e seu uso como moduladores de receptor de prostaglandina d2

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]